InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

TriSalus Life Sciences, Inc.

TLSI Clue Score59
United States Fiscal year ends December CIK 0001826667
$4.06 -1.69% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $4.06 −17.98% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 10 Aug 2023. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2021Operating income−3.0Net income4.8Fiscal year 2022Revenue12.4Operating income−36.4Net income−47.2 −1,089.8%EPS, diluted−161.55Fiscal year 2023Revenue18.5 +49.3%Operating income−54.5Net income−59.4EPS, diluted−6.77Fiscal year 2024Revenue29.4 +59.0%Operating income−36.2Net income−30.0EPS, diluted−1.31Fiscal year 2025Revenue45.2 +53.4%Operating income−26.9Net income−39.2EPS, diluted−1.84
FY2021FY2022FY2023FY2024FY2025
Revenue n/a 12.4 18.5 29.4 45.2
Growth +49.3% +59.0% +53.4%
Operating income −3.0 −36.4 −54.5 −36.2 −26.9
Net income 4.8 −47.2 −59.4 −30.0 −39.2
Growth −1,089.8%
EPS, diluted n/a −161.55 −6.77 −1.31 −1.84

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2021Fiscal year 2022Gross margin81.8%Operating margin−293.9%Net margin−380.6%Free cash flow margin−265.9%Fiscal year 2023Gross margin85.9%Operating margin−294.3%Net margin−320.7%Free cash flow margin−276.4%Fiscal year 2024Gross margin86.1%Operating margin−122.9%Net margin−102.1%Free cash flow margin−139.9%Fiscal year 2025Gross margin84.6%Operating margin−59.7%Net margin−86.9%Free cash flow margin−41.9%
FY2021FY2022FY2023FY2024FY2025
Gross margin n/a 81.8% 85.9% 86.1% 84.6%
Operating margin n/a −293.9% −294.3% −122.9% −59.7%
Net margin n/a −380.6% −320.7% −102.1% −86.9%
Free cash flow margin n/a −265.9% −276.4% −139.9% −41.9%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2021Operating cash flow−1.7Fiscal year 2022Operating cash flow−32.3Capital expenditure−0.7Free cash flow−33.0Buybacks−232.4Fiscal year 2023Operating cash flow−50.6Capital expenditure−0.6Free cash flow−51.2Fiscal year 2024Operating cash flow−40.8Capital expenditure−0.3Free cash flow−41.2Fiscal year 2025Operating cash flow−18.0Capital expenditure−0.9Free cash flow−18.9
FY2021FY2022FY2023FY2024FY2025
Operating cash flow −1.7 −32.3 −50.6 −40.8 −18.0
Capital expenditure n/a −0.7 −0.6 −0.3 −0.9
Free cash flow n/a −33.0 −51.2 −41.2 −18.9
Growth
Buybacks n/a −232.4 n/a n/a n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2021Cash0.2Shareholders’ equity−129.6Fiscal year 2022Cash9.4Shareholders’ equity−177.1Fiscal year 2023Cash11.8Total debt0.0Net cash (debt)11.8Shareholders’ equity−27.1Fiscal year 2024Cash8.5Total debt22.1Net cash (debt)−13.6Shareholders’ equity−25.9Fiscal year 2025Cash20.4Total debt33.0Net cash (debt)−12.6Shareholders’ equity−33.9
FY2021FY2022FY2023FY2024FY2025
Cash 0.2 9.4 11.8 8.5 20.4
Total debt n/a n/a 0.0 22.1 33.0
Net cash (debt) n/a n/a 11.8 −13.6 −12.6
Shareholders’ equity −129.6 −177.1 −27.1 −25.9 −33.9

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023† 31 Dec 2023 FY2024† 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
n/a 12.4 18.5 29.4 45.2
Growth +49.3% +59.0% +53.4%
n/a 2.3 2.6 4.1 7.0
n/a 10.1 15.9 25.3 38.2
Growth +56.9% +59.2% +50.8%
n/a 21.4 29.8 17.7 15.0
3.0 12.5 23.5 18.0 21.5
−3.0 −36.4 −54.5 −36.2 −26.9
Growth
4.8 −47.2 −59.4 −30.0 −39.2
0.0 0.0 0.0 0.0 0.0
4.8 −47.2 −59.4 −30.0 −39.2
Growth −1,089.8%
Per share
n/a −161.55 −6.77 −1.31 −1.84
n/a −161.55 −6.77 −1.31 −1.84
Growth
n/a 0.3 9.4 25.3 37.9
n/a 0.3 9.4 25.3 37.9
Growth +2,934.7% +169.6% +49.6%

† The diluted share count jumps at 2023 and 2024, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 4 of 5 years on file.